Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 13, 2025

RRP9 Promotes Esophageal Squamous Cell Carcinoma Progression through E2F1 Transcriptional Regulation of CDK1.

View Full Paper
Ask AI
Bookmark
Share

Authors

GHGang HeYWYilong WanYZYanbo Zhu

Discussion

Loading...

Member takes

Overview

This analysis uncovers RRP9's role in regulating CDK1 through E2F1 in esophageal squamous cell carcinoma, indicating a potential therapeutic target.

Key Points

  • RRP9 enhances esophageal squamous cell carcinoma progression, indicating its potential role as a tumor driver.
  • High RRP9 expression correlates with poor patient prognosis, emphasizing the need for targeted therapies.
  • The study identifies E2F1-mediated transcriptional regulation of CDK1 as a mechanistic pathway for RRP9's tumor-promoting effects.
  • Findings present RRP9 as a significant candidate for therapeutic targeting in managing esophageal squamous cell carcinoma.

Cite This Study

He et al. (2025) studied this question.

synapsesocial.com/papers/68d41ee7713b0b5dfea6863dhttps://doi.org/10.1002/adbi.202500220
View Full Paper
Ask AI
Bookmark
Share